JP2021511298A5 - - Google Patents
Info
- Publication number
- JP2021511298A5 JP2021511298A5 JP2020538029A JP2020538029A JP2021511298A5 JP 2021511298 A5 JP2021511298 A5 JP 2021511298A5 JP 2020538029 A JP2020538029 A JP 2020538029A JP 2020538029 A JP2020538029 A JP 2020538029A JP 2021511298 A5 JP2021511298 A5 JP 2021511298A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- siglec
- variable region
- region containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862616317P | 2018-01-11 | 2018-01-11 | |
| US62/616,317 | 2018-01-11 | ||
| PCT/US2019/013316 WO2019140273A1 (en) | 2018-01-11 | 2019-01-11 | Anti-siglec-7 antibodies having reduced effector function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511298A JP2021511298A (ja) | 2021-05-06 |
| JP2021511298A5 true JP2021511298A5 (cg-RX-API-DMAC7.html) | 2022-02-07 |
| JP7342005B2 JP7342005B2 (ja) | 2023-09-11 |
Family
ID=67219179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538029A Active JP7342005B2 (ja) | 2018-01-11 | 2019-01-11 | エフェクター機能が減少した抗siglec-7抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11912766B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3737410A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7342005B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019208025A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3087968A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019140273A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115960235A (zh) | 2015-08-28 | 2023-04-14 | 艾利妥 | 抗siglec-7抗体及其使用方法 |
| CN119841953A (zh) | 2018-06-08 | 2025-04-18 | 艾利妥 | 抗siglec-7抗体及其使用方法 |
| WO2023091512A2 (en) * | 2021-11-16 | 2023-05-25 | Allakos, Inc. | Antibodies to anti-siglec-9 and multispecific antibodies targeting siglec-7 and siglec-9 |
| KR20250035502A (ko) * | 2022-03-31 | 2025-03-12 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | Siglec-7을 표적으로 하는 이중특이적 자연 살해 인게이저 |
| KR20240168432A (ko) * | 2022-03-31 | 2024-11-29 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | 인간 Siglec-7에 대한 항체 및 이의 면역요법을 위한 용도 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007120815A2 (en) | 2006-04-12 | 2007-10-25 | The Regents Of The University Of California | Methods for treating lymphocyte-associated disorders by modulation of siglec activity |
| AU2008272330A1 (en) | 2007-07-04 | 2009-01-08 | Forerunner Pharma Research Co., Ltd. | Anti-Muc17 antibody |
| CN104520324A (zh) | 2012-02-24 | 2015-04-15 | 施特姆森特Rx股份有限公司 | Dll3调节剂及其使用方法 |
| ES3066738T3 (en) * | 2012-12-21 | 2026-05-14 | Aveo Pharmaceuticals Inc | Anti-gdf15 antibodies |
| ES2861313T3 (es) * | 2014-08-07 | 2021-10-06 | Daiichi Sankyo Co Ltd | Anticuerpo anti Orai1 |
| JP2017532025A (ja) | 2014-09-10 | 2017-11-02 | イナート・ファルマ・ソシエテ・アノニムInnate Pharma Pharma S.A. | 交差反応性siglec抗体 |
| CN115960235A (zh) | 2015-08-28 | 2023-04-14 | 艾利妥 | 抗siglec-7抗体及其使用方法 |
| MX2018006072A (es) * | 2015-11-19 | 2018-08-01 | Squibb Bristol Myers Co | Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos. |
| AU2017207807A1 (en) | 2016-01-12 | 2018-07-12 | Palleon Pharmaceuticals Inc. | Use of Siglec-7 or Siglec-9 antibodies for the treatment of cancer |
| CN108699158B (zh) * | 2016-03-08 | 2022-06-03 | 依奈特制药公司 | Siglec中和抗体 |
| IL264674B2 (en) * | 2016-08-05 | 2023-09-01 | Allakos Inc | Antibodies to siglec7 for cancer treatment |
-
2019
- 2019-01-11 WO PCT/US2019/013316 patent/WO2019140273A1/en not_active Ceased
- 2019-01-11 AU AU2019208025A patent/AU2019208025A1/en not_active Abandoned
- 2019-01-11 CA CA3087968A patent/CA3087968A1/en active Pending
- 2019-01-11 JP JP2020538029A patent/JP7342005B2/ja active Active
- 2019-01-11 US US16/961,197 patent/US11912766B2/en active Active
- 2019-01-11 EP EP19739010.7A patent/EP3737410A4/en not_active Withdrawn